What do systematic reviews say?

Abiraterone + ADT vs ADT only

Abiraterone + ADT probably leads to lower time to disease progression measured at a median compared with ADT alone (moderate certainty).

• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for… 2020 · Cochrane Headline outcomes only
  HR 0.35 [0.26, 0.49]
  2 studies · 2097 participants
  Moderate